Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary L Rosner

Showing results (21-30 of 119) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2002
Randomized discontinuation design: application to cytostatic antineoplastic agentsGary L Rosner, Walter Stadler, Mark J Ratain
Biometrics|September 11, 2007
Bayesian inference for the lead time in periodic cancer screeningDongfeng Wu, Gary L Rosner, Lyle D Broemeling
Biometrics|April 27, 2022
A Bayesian model with application for adaptive platform trials having temporal changesChenguang Wang, Min Lin, Gary L Rosner, et al.
Journal of the American Statistical Association|July 19, 2011
Estimating the Term Structure With a Semiparametric Bayesian Hierarchical Model: An Application to Corporate BondsAlejandro Cruz-Marcelo, Katherine B Ensor, Gary L Rosner
Statistics in Medicine|October 29, 2018
A Bayesian design for phase I cancer therapeutic vaccine trialsChenguang Wang, Gary L Rosner, Richard B S Roden
Journal of Neuro-Oncology|March 26, 2013
'Elderly' patients with newly diagnosed glioblastoma deserve optimal careMatthias Holdhoff, Gary L Rosner, Sara Alcorn, et al.
The International Journal of Biostatistics|May 23, 2012
The lead time distribution when lifetime is subject to competing risks in cancer screeningDongfeng Wu, Karen Kafadar, Gary L Rosner, et al.
Bayesian Analysis|September 13, 2011
Semi-parametric Bayesian Inference for Multi-Season Baseball DataFernando A Quintana, Peter Müler, Gary L Rosner, et al.
Biostatistics (Oxford, England)|October 3, 2017
Dependent generalized Dirichlet process priors for the analysis of acute lymphoblastic leukemiaWilliam Barcella, Maria De Iorio, Stefano Favaro, et al.
Statistics in Biopharmaceutical Research|November 13, 2018
CommentA Ivanova, K M Anderson, Gary L Rosner, et al.
Pageof 12

Showing results (21-30 of 119) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2002
Randomized discontinuation design: application to cytostatic antineoplastic agentsGary L Rosner, Walter Stadler, Mark J Ratain
Biometrics|September 11, 2007
Bayesian inference for the lead time in periodic cancer screeningDongfeng Wu, Gary L Rosner, Lyle D Broemeling
Biometrics|April 27, 2022
A Bayesian model with application for adaptive platform trials having temporal changesChenguang Wang, Min Lin, Gary L Rosner, et al.
Journal of the American Statistical Association|July 19, 2011
Estimating the Term Structure With a Semiparametric Bayesian Hierarchical Model: An Application to Corporate BondsAlejandro Cruz-Marcelo, Katherine B Ensor, Gary L Rosner
Statistics in Medicine|October 29, 2018
A Bayesian design for phase I cancer therapeutic vaccine trialsChenguang Wang, Gary L Rosner, Richard B S Roden
Journal of Neuro-Oncology|March 26, 2013
'Elderly' patients with newly diagnosed glioblastoma deserve optimal careMatthias Holdhoff, Gary L Rosner, Sara Alcorn, et al.
The International Journal of Biostatistics|May 23, 2012
The lead time distribution when lifetime is subject to competing risks in cancer screeningDongfeng Wu, Karen Kafadar, Gary L Rosner, et al.
Bayesian Analysis|September 13, 2011
Semi-parametric Bayesian Inference for Multi-Season Baseball DataFernando A Quintana, Peter Müler, Gary L Rosner, et al.
Biostatistics (Oxford, England)|October 3, 2017
Dependent generalized Dirichlet process priors for the analysis of acute lymphoblastic leukemiaWilliam Barcella, Maria De Iorio, Stefano Favaro, et al.
Statistics in Biopharmaceutical Research|November 13, 2018
CommentA Ivanova, K M Anderson, Gary L Rosner, et al.
Pageof 12